Genmab Relies On Pipeline As J&J Opts Out Of Next-Gen Darzalex

Epkinly, Rina-S, Acasunlimab To Deliver Revenue Growth

 
• By Mandy Jackson
  
With or without a GEN3014 deal, Genmab is seeking growth through late-stage dealmaking (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Scrip